Sign in to view content

Phase 2 Trial of Ciliary Neurotrophic Factor for Macular Telangiectasia

Video
Published 2017

Related

Optimization of the Port Delivery System With Ranibizumab (PDS) Implant Insertion Procedure in the LADDER Phase 2 Trial
Mark R. Wieland, MD
Annual Meeting Talks
2019
Episode 31- FLUID Study - Dr. Robyn Guymer
Keyvan Koushan, MD, FRCSC
Member Podcasts
2019
Protocol T Extension Results
John A. Wells, MD, FACS
Updates from the Field
2019

Category: Hereditary Retinal Disease & Genetics

See more

Updates from the Field